BLUE CROSS BLUE SHIELD NORTH DAKOTA Raising awareness of men's health through facial hair
During their lifetime, one in six men will be diagnosed with prostate cancer and it is projected that nearly 30,000 men will die of prostate cancer in America in 2013. Yet, awareness and advocacy on b... Posted on 12/3/13 at 2:32 PM
THE DULLUM FILE Going Back to Med School
Each year about this time I get a littletaste of what it's like to be in medical school. I look forward to talking with second-year medical students at the UND School of Medicine & Health Sciences... Posted on 2/15/13 at 1:46 PM
Medicare officials said that the program will pay the $93,000 cost of prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the disease an extra four months to live.
A drug commonly used to shrink enlarged prostate glands also increases the accuracy of the test used to detect aggressive forms of prostate cancer, Washington University researchers have found.
Dr. Gerald Andriole, chief of urologic surgery at Washington University School of Medicine, said a four-year study confirms that men who used the drug Avodart (the generic form is called dutasteride) received more accurate readings on their prostate specific antigen tests, especially if they were developing forms of aggressive cancer.
A man whose index finger is longer than his ring finger has a statistically lower risk of developing prostate cancer compared to those whose index fingers are shorter than their ring fingers, scientists from The University of Warwick and the Institute of Cancer Research, UK, revealed in the British Journal of Cancer. The risk was one third lower for those with the longer index finger.
Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to researchers at Duke University Medical Center. Researchers also found that higher doses of the drugs were associated with lower risk of recurrence.
The prostate study has the potential to change care right away. About 20 percent of the nearly 200,000 men diagnosed with the disease each year in the United States are like those in the study — with cancer that has spread to the area around the prostate.
The American Cancer Society is urging doctors to make clearer to men that the PSA blood test used to screen for prostate cancer has limits and may lead to unnecessary treatments that do more harm than good. It also says digital rectal exams should be an option rather than part of a standard screening.
State education officials said this week that 300 school districts endorsed a teacher pay approach that bases raises partly on student performance, something they’d be willing to try if the state lands $330 million in federal aid.
Associated Press/Forum Communications
, January 22, 2010
A news report released by Reuters has found that a molecule that is found in curry can kill esophageal cancer cells in a laboratory, suggesting that it might be an anti-cancer treatment in the near future. This common spice has long been suspected as a treatment for various ailments.
View your ad here! Cost effective targeted advertising. Contextual advertising starting as low as $79/month. This includes targeted ad delivery and search results! Add your business to the Marketplace »